Carolinas Hematology-Oncology Associates — Charlotte, North Carolina

Carolinas Hematology-Oncology Associates is a clinical research site located in Charlotte, North Carolina, United States 28203.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Carolinas Hematology-Oncology Associates has participated in 17 clinical trials.

Therapeutic areas: Neurofibromatosis Type 1, Sarcoma, Gastrointestinal Stromal Tumors.

Sponsors: Sarcoma Alliance for Research through Collaboration, European Organisation for Research and Treatment of Cancer - EORTC, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolinas Hematology-Oncology Associates?

Carolinas Hematology-Oncology Associates has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolinas Hematology-Oncology Associates conducted?

Carolinas Hematology-Oncology Associates has 17 clinical trials on record. Their work covers Neurofibromatosis Type 1, Sarcoma, Gastrointestinal Stromal Tumors.

Is Carolinas Hematology-Oncology Associates accredited by Crixeo Clinical Trials?

Carolinas Hematology-Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolinas Hematology-Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.